|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 366.29 USD | -1.42% |
|
+0.80% | +11.91% |
| 16/07 | Merck gets US FDA nod for first-in-its-class oral cholesterol drug | RE |
| 13/07 | BofA Securities Adjusts Amgen Price Target to $312 From $307 | MT |
| Market Cap | 20TCr 17TCr 16TCr 15TCr 28TCr 19,03800Cr 28TCr 1,90500Cr 75TCr 9,32400Cr 74TCr 73TCr 32,09700Cr | P/E 2026 * |
24x | P/E 2027 * | 22x |
|---|---|---|---|---|---|
| Enterprise Value | 24TCr 21TCr 19TCr 18TCr 34TCr 23,07700Cr 34TCr 2,31000Cr 91TCr 11,30200Cr 90TCr 88TCr 38,90700Cr | EV / Sales 2026 * |
6.35x | EV / Sales 2027 * | 6.05x |
| Free-Float |
99.78% | Yield 2026 * |
2.75% | Yield 2027 * | 2.91% |
Last Transcript: Amgen Inc.
| 1 day | -1.42% | ||
| 1 week | +0.80% | ||
| Current month | +1.15% | ||
| 1 month | +7.21% | ||
| 3 months | +3.09% | ||
| 6 months | +10.86% | ||
| Current year | +11.91% |
| 1 week | 353.95 |  | 378.54 |
| 1 month | 337.6 | | 378.54 |
| Current year | 318.21 | | 391.29 |
| 1 year | 269.77 | | 391.29 |
| 3 years | 228.21 | | 391.29 |
| 5 years | 198.64 | | 391.29 |
| 10 years | 133.64 | | 391.29 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Bradway
CEO | Chief Executive Officer | 63 | 01/05/2012 |
| Director of Finance/CFO | 62 | 13/05/2010 | |
Peter Griffith
DFI | Director of Finance/CFO | 67 | 01/01/2020 |
| Director | Title | Age | Since |
|---|---|---|---|
Robert Bradway
CHM | Chairman | 63 | 01/01/2013 |
Tyler Jacks
BRD | Director/Board Member | 65 | 01/01/2012 |
Robert Eckert
BRD | Director/Board Member | 71 | 01/01/2012 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 19/05/26 | Free | Director | 665 | 0.0001% | ||
| 19/05/26 | Free | Director | 665 | 0.0001% | ||
| 19/05/26 | Free | Director | 665 | 0.0001% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.42% | +0.80% | +22.81% | +60.77% | 20TCr | |
| +0.85% | -0.80% | +54.84% | +163.70% | 1,05100Cr | |
| +1.23% | -1.53% | +55.26% | +59.07% | 61TCr | |
| +0.04% | +2.58% | +32.96% | +88.75% | 45TCr | |
| +0.78% | -0.71% | +30.04% | +24.61% | 33TCr | |
| +1.41% | +0.58% | +33.92% | +47.20% | 28TCr | |
| -0.27% | -1.87% | +22.13% | +23.47% | 26TCr | |
| -1.76% | +2.37% | -22.19% | -38.45% | 22TCr | |
| -1.48% | +3.43% | +23.42% | +73.31% | 17TCr | |
| -0.36% | +3.64% | +1.91% | -30.15% | 14TCr | |
| Average | +0.08% | +0.85% | +25.51% | +47.23% | 37.18TCr | |
| Weighted average by Cap. | +0.28% | +0.16% | +36.38% | +77.21% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.77TCr 3.3TCr 3.04TCr 2.81TCr 5.29TCr 3,63500Cr 5.41TCr 36TCr 14TCr 1,78000Cr 14TCr 14TCr 6,12900Cr | 3.87TCr 3.38TCr 3.12TCr 2.88TCr 5.42TCr 3,72500Cr 5.54TCr 37TCr 15TCr 1,82400Cr 15TCr 14TCr 6,28000Cr |
| Net income | 821.92Cr 718.27Cr 662.8Cr 610.94Cr 1.15TCr 79TCr 1.18TCr 7.92TCr 3.12TCr 39TCr 3.09TCr 3.02TCr 1,33400Cr | 885.11Cr 773.5Cr 713.76Cr 657.91Cr 1.24TCr 85TCr 1.27TCr 8.53TCr 3.36TCr 42TCr 3.32TCr 3.25TCr 1,43700Cr |
| Net Debt | 4.19TCr 3.67TCr 3.38TCr 3.12TCr 5.88TCr 4,03900Cr 6.01TCr 40TCr 16TCr 1,97800Cr 16TCr 15TCr 6,81000Cr | 3.63TCr 3.17TCr 2.93TCr 2.7TCr 5.08TCr 3,49500Cr 5.2TCr 35TCr 14TCr 1,71200Cr 14TCr 13TCr 5,89200Cr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 17/26/17 | $366.29 | -1.42% | 28,61,314 |
| 16/26/16 | $371.58 | +3.70% | 23,55,743 |
| 15/26/15 | $358.32 | +0.86% | 18,37,923 |
| 14/26/14 | $355.25 | -1.44% | 18,62,958 |
| 13/26/13 | $360.45 | -0.81% | 20,64,665 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- AMGN Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
